Myocarditis

What’s the Truth About Covid Vaccines and Heart Attacks?

A further three football players collapsed during play this week, bringing new interest to the question of what might be the connection between this unusually high number of on-field medical emergencies and the Covid vaccines. Football pundit Trevor Sinclair got into hot water for raising the question on-air, while scientists argued that the disturbing trend is more likely to be a consequence of Covid itself than the vaccines.

Presumably something lies behind the recent rise, which according to some analysts has involved 21 sudden deaths (most heart-related) of FIFA players so far in 2021, compared to around 4.2 in an average year (with a standard deviation of 2.0). Assuming this isn’t a reporting phenomenon, this is an extraordinary spike and highly statistically significant.

The two major unusual factors this year are the presence of SARS-CoV-2 and the Covid vaccination programme. However, only two such deaths were reported in 2020, when Covid was also around, which would seem to lend weight to a vaccine explanation.

The vaccines are known to affect the heart and cardiovascular system in some cases, which is why blood clots and heart inflammation (e.g. myocarditis) are among the side-effects listed and why a number of countries have ceased using some of the vaccines in younger age groups. This means the idea that there could be a link between an unusual spate of heart-related emergencies and the vaccines shouldn’t be dismissed out of hand.

Why Has There Been a Rise in Non-Covid-Related Heart Attacks Since the Vaccine Roll-Out?

There follows a guest post by the academic economist who regularly contributes to the Daily Sceptic.

We have known for some time that the vaccines can lead to myocarditis, a condition that causes the heart muscle to swell. Myocarditis is typically a serious illness and in its worst cases can cause cardiac arrest and death. There are also some indications that the risk for myocarditis from the vaccine may be higher in younger people and especially in younger men – a group that is not seriously at risk from COVID-19.

This was clearly not an effect picked up by the clinical trials. We already know that the clinical trials have proved misleading when it comes to protection against infection – and there are also indications that the trials may have been misleading on how well the vaccine prevents hospitalisation and death. Since the vaccine was launched, independent macro-level data has consistently proved more scientifically reliable than micro-level trial data.

So, can we get any numbers on macro-level heart failure? Yes, in fact, we can – and the results are disturbing. The Government publishes a weekly report on excess mortality in England and it includes a breakdown by cause. One of these causes of death is heart failure. Usefully, the data also tells us how many of the deaths from heart failure were due to COVID-19. Using this data, we can calculate excess deaths from heart failure not caused by COVID-19. Let us compare the period in which the vaccine has been active, to the period in which it was not.

Here we see that excess deaths from heart failure that were not caused by COVID-19 are more than 12 times higher in 2021 than they were in 2020. Could these be myocarditis deaths induced by the vaccine? Possibly. There is no way to be totally sure. But the results are worrying and merit further investigation.

One statistical trick we might use to tease out causality is to take the ratio of COVID-19-induced excess heart failures to non-COVID-19-induced excess heart failures and compare this to the number of people vaccinated under-30 – i.e., the group most vulnerable to vaccine-induced myocarditis. (Note: there is no age-specific data on non-Covid-related heart attacks.)

New Zealand Woman Dies After Receiving Pfizer Covid Vaccine

The whole of New Zealand was plunged into lockdown following the reporting of a single Covid ‘case’ earlier this month. But the main response to today’s reporting of a death in the country linked to the Pfizer vaccine appears to be highlighting just how safe the jab really is. Sky News has the story.

The Covid Independent Safety Monitoring Board (CV-ISMB) did note that there were other medical issues occurring simultaneously, which may have influenced [the woman’s] death following her vaccination.

“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer Covid vaccine,” the Ministry said in a statement, without giving the woman’s age.

The Ministry added the vaccine monitoring panel attributed the death to myocarditis, a rare but known side effect of the vaccination.

Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms.

Last month, New Zealand Medicines and Medical Devices Safety Authority (Medsafe) issued a safety alert on myocarditis to raise awareness of the side effect.

All cases of deaths following vaccinations are referred to the CV-ISMB for review.

The board’s Chairman, Dr. John Tait, said: “We want to ensure that the outcomes from this investigation are widely available for others to learn from.

“The Pfizer vaccine is highly effective in protecting against serious illness and death from Covid and we remain confident about using it in New Zealand.”

The Health Ministry has reassured people that the benefits of the jab continue to “greatly outweigh” the risk of Covid and vaccine side effects.

In response, Pfizer said it recognised there could be incidences of myocarditis after vaccinations but such side effects were extremely rare.

Worth reading in full.

Raising the Alarm on Myocarditis After Covid Vaccination

We’re publishing an original article today on the risks of heart problems following receipt of a Covid vaccine by Dr Clare Craig, a Diagnostic Pathologist in London and member of HART, and Dr Andrew G. Bostom, MD, a MS Research Physician at Brown University’s Center For Primary Care and Prevention at the Memorial Hospital of Rhode Island. They originally submitted it to the BMJ as a ‘Rapid Response’, but it was rejected. Here is an extract:

The FDA has expressed concerns around the rate of reported myocarditis within the VAERS reporting system, especially in the young. A presentation by the FDA on June 10th 2021 compared the reported rates of myocarditis with background expected rates, with data up to May 31st 2021. However, the expected rates to which observed rates were compared were those expected over a 31-day period. For under-18s, 90% of cases had an onset by day five after vaccination, making comparison with expected rates over 31 days unreasonable. A further meeting on June 23rd 2021 examined the reports in a seven day window with data up to 11 June 2021. A four fold increase above baseline was evident in the seven days after the first dose for under-24 year-olds, rising to over 27-fold for the seven days after the second dose. The rate per million doses given in males 12-17 years old was 17 times higher than in men aged over 50 years seven days after the first dose, rising to 74 times seven days after the second dose. (For females the risk was 50% higher and 13 times higher respectively.)

Worth reading in full.